ema prac naion semaglutide very rare side effect 2025 GLP-1 Drug Can Cause Rare, Potentially Blinding Effect, Warns EMA says Ozempic, Wegovy may

Assess insulin resistance markers (fasting insulin, HOMA-IR, C-peptide, proinsulin), body composition, gut and hormone panels, inflammatory markers, and toxin/detox status

Medications approved for diabetes management (e.g., Ozempic, Mounjaro) may be covered when prescribed for FDA-approved diabetic indications, subject to medical necessity review." This creates the paradox: semaglutide 1.0 mg (Ozempic) for diabetes is covered

We'll discuss which fits you at consultation

Ontario, British Columbia, Alberta, and Quebec all have pathways to public coverage

Stay well-hydrated, consume adequate fiber, and eat smaller, frequent meals to manage combined GI effects

Refer to the product label for full ingredient details